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ABSTRACT 
Effects of Gold Compounds on Rat Behavior 
by 
Jonas Kaye, Doctor of Philosophy 
Utah State University, 1969 
Major Professor: Heber C, Sharp 
Department: Psychology 
Seven rats were trained on Fixed Rati o 20 and two on Fixed Ratio 
12 Escape Schedules until a stable baseline was established. Five 
of the subjects were administered gold thioglucose, three received 
gold thiomalate, and one was injected with gold, gold thioglucose, and 
gold thiomal ate, allowing for an i ntrasubject comparison. Colloidal 
gold appeared to suppress response rate for one or two sessions, while 
gold thioglucose and gold thiomalate suppressed normal response rates 
from several to a number of sessions . This response rate suppression 
was often followed by gradual recovery, although in several subjects 
recovery of response rate could not be achieved prior to termination 
of the experiments , 
viii 
The drop i n response rate was more consistent for the gold thiomalate-
treated subjects than for the gold thioglucose group. A toxic effect 
of the injected compounds was manifest as a loss of weight, which was 
regularly associated with a drop in response rate . This weight reduc-
tion was greatest in the gold thiomalate - injected animals, indicating 
that gold thiomalate is probably more toxic than gold thioglucose to rats. 
Tolerance was developed for gold th i oglucose and gold thiomalate, 
as indicated by smaller response rate decrements after repeated 
ix 
injections of the compound. As a consequence of repeated drug admin-
istrations, the animals demonstrated that they could tolerate a 1 
milligram per gram of body weight dose of gold thioglucose if the 
dosage was increased gradual ly f rom a low-dosage initial injection . 
This dosage of 1 milligram per gram of body weight is double the 
amount required to produce demonstrable hypothalamic lesions in the rat . 1 
Previous investigations have failed to demonstrate this degree of 
tolerance in rats, primari ly because the animals did not have the 
opportunity to adapt themselves to this treatment. 
Decrease in spontaneous activity on a balance beam apparatus was 
observed in several rats following administration of the larger gold 
thioglucose dosages (i . e. , 0, 5 mil l i grams per gram of body weight to 
1. 0 mi lligram per gram of body weight), as well as following the 
admi ni stration of gol d th i omal ate , 
Dosages of 20 mi lligrams to 50 milligrams of gold chloride were 
lethal to two rats , 
The heavy dosage of gold th i ogl ucose administered to the female 
rat subj ects at Utah State Univers i ty (i . e , , up to 1 mg per gram of 
body weight), although potent i ally producing extensive hypothalamic 
les i ons, 2 did not produce demonstrable hyperphagia or obesity, probably 
due to the anorexia and hypophagi a associated with liver and kidney 
damage,3 which could counteract the hyperphagia expected to be associated 
1J. W. Wagner and J. DeGroot, "Effect of Gold Thioglucose Injections 
on Survival, Organ Damage and Obesity in the Rat, 11 Soc. Exp. BioZ. and 
Med. , CXII (1963), 33-37. 
2 I bid . 
3w. D. Block, 0. H, Buchanan, and R. H. Freyberg, "Metabolism, 
Toxicity, and Manner of Action of Gold Compounds used in the Treatment of 
Arthritis," J. of Pharmac , and ExptZ . Therap., LXXVI (1942), 355-357. 
with the extensive hypothalamic lesions produced at dosages over 0.5 
milligram per gram of body weight following gold thioglucose admin-
. t t · 4 , s ra , on. 
( 111 pages) 
4wagner and DeGroot, op. cit. 
X 
INTRODUCTION 
Gold, gold thioglucose, and gold thiomalate are drugs which are 
currently utilized in medical practice in the diagnosis and treatment 
of cancer and rheumatoid arthritis (Drill, 1954), Yet, these compounds 
would not have received much attention from behavioral pharmacologists 
within the larger sphere of psychology, had not Brecher and Waxler 
(1949) discovered, following a single massive dose of gold thioglucose 
into a mouse, that within weeks the animals practically doubled its 
size from overeating (hyperphagia) , The problem, which became obvious 
in time, was an apparent discrepancy between the obesity and hypothal-
amic lesions (Marshall, Barnett, and Mayer, 1955) produced following 
a gold thioglucose injection and a lack of obesity and overt symptoms 
in humans receiving this drug during arthritic therapy. 
The purpose of this investigation was to evaluate the apparent 
effects that gold-containing compounds have on response rates and 
behaviors as related to chemical lesioning of hypothalamic areas and 
associated neural structures , 
REVIEW OF THE LITERATURE 
The complexity of gold and its compounds is of such magnitude--
whether chemical, biological, or behavioral factors are considered--
that it would be most advantageous to consider such phenomena separ-
ately, prior to attempting to integrate or combine these various 
attributes. A natural starting point is the history of gold and its 
derivatives . 
Medical History of Gold and 
its Compounds 
Gold, as one of the precious metals, was highly regarded as a 
medicinal agent i n ancient t imes. It was said to be used in the treat-
ment of syphilis at the time of Paracelsus (Drill, 1954). In the 
latter half of the ni neteenth century, following the emergence of 
chemistry as a science, gold and some of its compounds regained their 
popularity as the rapeuti c agents based on a more r.ational basis . Gold 
compounds were widely used in the first half of the twentieth century 
to treat tuberculosis, rheumatoid arthritis, and skin diseases such 
as lupus erythrematosis, 
Gold chloride was one of the earliest compounds of the metal gold 
which were utilized in medical practice . In Remington's Practice of 
Pharmacy (1905), an official compendium for the medical and pharma-
ceutical professions, gold chloride was combined with nitrohydrochloric 
acid to give gold and sodium chloride, the combination of which is 
medicinally equivalent to gold chloride , This salt mixture (i.e., gold 
2 
and sodium chloride) was used internally as an alterative at a dose of 
from 0.005 to 0,016 gm. By 1917, Holland had published his text, Mediaal 
Chemistry and Toxiaology (Holland, 1940), in which he stated that the 
toxic effects of gold and sodium chloride are similar to those of 
mercuric chloride; i ,e o, gastro-enteritis, mental disturbances, and 
convulsions . Soon gold chloride disappeared from the scene as a 
medicinal agent , A closely-related drug, gold bromide, had come into 
prominence in the latter half of the nineteenth century, but it too fell 
into disfavor . In 1889, Gaubert reported to the French Academy that 
gold bromide had a more efficacious and more durable action in epilepsy 
than the other bromides and that it was better tolerated (Wood, 1940). 
Toward the middle of the twentieth century (Wood, 1940), medical 
opinion was that the soluble salts of gold are actively poisonous 
and that their toxic effects, like those of mercury salts, appear to 
be due to their local irritant action on the alimentary canal and on 
the kidneys . Perhaps it was due to the lack of reliable data about 
the gold compounds--or possibly other causes--that the medical profession 
continued utilizing the gold compounds i n therapy, although on a smaller 
scale . 
Currently, gold in its colloidal (i ,e . , finely divided metallic 
particles) radioactive form is a diagnostic agent for tumor detection 
(Drill, 1954), as well as in the treatment of the malignant tumors. 
Gold thioglucose and gold thiomalate are utilized frequently in 
certain cases of rheumatoid arthritis, and are considered to be the 
drugs of choice in such cases by some of the leading rheumalogists 
(Goodman and Gilman, 1965), 
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Colloidal radioactive gol d can be given in small amounts intra-
venously (Root et al o, 1954) i n order to obtain scintiscan records 
over such organs as the li ver o During the early stages of rheumatoid 
arthritis, gold th i ogl ucose and gol d thiomalate, as well as several 
other similar gold compounds, have been demonstrated to be assoc iated 
with the reduction of the i nflammatory process . The patient fre-
quently repor ts rel i ef f rom pai n, but the mechanism of action remains 
unknown (Drill, 1954), A number of stud i es have been conducted to 
discover the mechani sm of the act i on of gold compou~ds over the years, 
without demonstrable success o 
Gold compounds (but not col lo i dal gold) are considered to be 
highly toxic by medical pract iti oners (Drill, 1954), Since the intro-
duction of the gold compounds i n arthritic therapy (i . e . , chryso-
therapy), the foll owi ng manifestations of toxi city (Remington, 1965) 
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have been frequently reported: pr uriti s, dermatitis, stomatis, 
gastrit i s, colitis; and rar ely, blood dyscrasi s, hepatitis, and neu-
rit i s , Although psychi atr i c abnormaliti es have only been i nfrequently 
reported (Hartfall, Garl and, and Gold i e, 1937), i n an exhaust i ve revi ew 
of the toxic effects of gold, Sundeli n (1941) reported cases with central 
and per i pheral nervous system mani festat i ons. Cerebral symptoms ranged 
from simple depression to f r ank psychosi s . In 1950, Myerson (1950) re-
ported a case of meni ngitis as an unusual complicat ion of chrysotherapy . 
The Chemi cal Nature of Gold 
and its Compounds 
Any considerat i on of the effects of a drug on a biological system 
necessitates an invest i gation of the chemical nature of the drug. One 
of the reasons is that it has long been known that there is a definite 
relationship between the effects of drugs with similar chemical con-
figurations or structural similarities and their actions on biological 
systems , Furthermore, the known solubility characteristics of drugs 
provide further clues as to possibilities of their distribution 
following admi nistration . Finally, the chemical structure also allows 
an investigator to frequently predict the pharmacodynamic or metabolic 
changes which contribute to the final observed effects , 
Metallic gold, the "noble" metal, was known and utilized both 
medicinally and ornamentally long before recorded history. It was 
one of the first metals to be ut i lized by mankind (Wood, 1940), and 
is found in many parts of the earth, occurring in both free and com-
bined states . Its chemical symbol is Au. It is a yellow metal, with 
a specific gravity of 19, 3 and atomic weight of 197. 2, and when 
finely divi ded, it may show a red, purple, or black color. It has a 
valence of one or three when chemically combined, In its metallic 
form--which includes colloidal gold--the mineral is insoluble and 
highly unreact i ve, 
Gold chloride, having the chemical formula AuC13 (Wood, 1940), 
is usually found in the form AuC13 • HC1•3H2 0. It is a bright golden-
yellow crystalline compound whi ch is soluble in water . It is 
hygroscopic and contains approximately 50 per cent gold . By 1940, 
it was rarely prescribed because of its strong irritant action and 
is currently only of historical interest , The gold in the compound 
is trivalent and ionic (i , e, , Au+++), Gold chloride is unstable in 
water, so that on long standing it i s changed (or reduced, in technical 
terminology) to its elemental state of zero valence; i , e., metallic 
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gold (Bjerrum, 1948). In an organic material such as sesame oil, this 
reaction occurs rapidly so that within hours the gold is in its 
metallic form (USU Laboratories, 1969), In bi ological fluids, rapi-
dity of reduction of the trivalent ionic gold to it s metallic form 
should proceed at an equal or greater rate than that observed with 
sesame oil . 
Gold thioglucose and gold (sodium) thiomalate are technically 
members of the so-called organo-metallic compounds because they are 
composed of the metal gold attached to an organic moiety. What makes 
them interesting and complicated is that the gold in both compounds 
is held in what is called a coordination complex. This means that 
the gold is ionic in nature--at least to some extent--as in gold 
chloride, but is somehow protected from being reduced by the organic 
moiety to which it i s attached o The practical significance of this 
coordination complex is demonstrated when the compound is put into 
sesame oil, for it remains stable for at least several months (USU 
Laborator i es, 1969). Gold thioglucose has been long known (Merck 
Index, 1952a; 1968), and has been marketed under the trade name Solganol 
(manufactured by Schering) . It i s a yellow powder whose aqueous solu-
tions are unstable on long stand i ng, Gold thiomalate is marketed as 
Myochrisine (manufactured by Merck) and is a white powder. The fact 
that the drugs are currently available from the manufacturers suggests 
that they are still used therapeutically on humans suffering from 
rheumatoid arthritis . 
The formulas for gold thioglucose and gold sodium thiomalate are 
as follows (Remington, 1965): 
6 
AuS-CH-CH2 COO Na 
I Gold sodium thiomalate COO Na•H20 
CH20H 
I H 
Gold thioglucose ~~ 
~; HO . . S-Au 
H OH 
Gold thioglucose is less soluble than gold sodium thiomalate. 
Gold sodium thiomalate, according to Drill (1954), is the only gold 
compound used medicinally which gives an appreciable concentration 
of ionic gold . 
The Biological Distribution and Known Effects of 
Gold, Gold Chloride, Gold Thioglucose, 
and Gold Thiomalate in 
Animals and Man 
Gold drugs were known and ut iliz ed medicinally for thousands of 
years prior to any precise scientif i c knowledge of their biological 
di stribut i on and biological effects . Once the biological information 
was available--almost without exception, scientific gains were made 
in those areas . For example, digitalis was known for hundreds of 
years in England and was associated by all varieties of medical prac-
titioners with the gout, but once it was found to specifically affect 
heart tissue and to be of a certain chemical structure, not only was 
it possible to utilize it in cardiology on a more rational basis, but 
the relationships which had been discovered between the type of drug 
and its biologi cal target organ resulted in the discovery of a host of 
7 
other similar drugs, thus advanci ng the whole field of cardiology. 
This same argument applies to the gold compounds. Until their biologi-
cal effects were discovered, no meani ngful explanation could be made 
for their effects, for example, on operant behavior in rats . A func-
tional relationship mi ght have been observed (i.e., a drop or gain in 
response rate i n relation to a drug injection); but without biological 
and chemical data, the causal relationsh i p remains obscure . Conse-
quently, it became imperative to review the data which has been 
accumulated to date on gold and i ts compoundso 
Metallic gold in it s colloidal form was found to be of great use 
in medical diagnosis and treatment of malignant tumors. It was con-
sidered for i nvestigat i on in th i s study because of its continuing 
importance i n medicine and its relation to the other drugs used in the 
follow in g experiments . The colloidal gold and radioactive gold are 
normally admi nis tered i n very small quantities (e.g n, 5 mg). The 
advantage of the isot opic form of administration for our purpose is 
that it allows for charting of the distribution of the go1d within the 
animal. In 1954, Root and his associates at the Oak Ridge Institute 
for Nuclear Studies (1954) studied the distribution and radiation 
effects of in travenous ly administered colloid al gold i n a number of 
pat i ents who had been inj ected with the radiogold . Their results, 
usi ng a Geiger tube and radi ograms, i ndicat ed that i n man most of the 
gold (60 to 94 per cent) local iz ed i n the liver. The spleen was 
second in its abil i ty to concentrate gold (5 to 16 per cent); while 
the kidneys and lungs and adrenals followed with decreasing concentra-
tions . No gold could be found i n the cerebral cortex . As for clinical 
effects, no immediate reactions were noted . Transient localized 
8 
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tenderness of the liver was noted in the patient who received the largest 
dose of the isotope (Root et al . , 1954), 
Haigler and Williams (1951) injected radiogold in doses of 10.0 
µc to 3 me in albino rats by various routes, including the intraperi-
toneal injections . They reported that the gold was phagocytized by 
the reticulo-endothelial cells of the liver, spleen, lung, kidney, and 
bone marrow" Ninety to 95 per cent was taken out of the blood by the 
liver and spleen, with very small quantit i es going to reticular 
elements elsewhere . 
Radioactive gold which was injected intraperitoneally into human 
patients (Bei erwaltes, Johnson, and Lalari, 1957) mixed with the fluid 
of the cavity within the first few hours, after which from 50 to 90 per 
cent of the radiogold disapp eare d from the cavity. Part of the gold 
was shown to be attached to surrounding serosa, while a little of the 
gold entered the blood. The urinary excretion of gold was low, being 
greatest during the first day, but generally less than 0.04 per cent of 
the total dose per day. In Russia, Kalistratova, Moskalev, and Sere-
bryakov (1966) inject ed colloidal gold (198 Au) into white rats . The 
routes of administration inclu ded intravenous, oral, endotracheal, and 
subcutaneous administrations . Their findings indicated that gold was 
slowly absorbed from the site of administration and accumulated mainly 
in the liver, spleen, and lymphatics , Gold administered parenterally 
was excreted slowly in the first four days, 
Radiogold has also been injected directly into glands (e.g., intra-
mammary injection) (Berg and Chris tophersen, 1956), In these cases, it 
was not distr i buted for any appreciable extent throughout the body. 
In Berg and Christophersen 1 s study, in which 60 dogs were injected in 
the mammary glands with the isotope gold, the radionuclide concentrated 
in the axillary, cervical, and latissimus dorsi lymph nodes--structures 
closely adjacent to the injection site. 
Such studies of the distribution of colloidal gold indicate that 
the final target organ for the deposition of gold is associated with 
the route of administration, so that if several animals are to be 
compared, identical routes of drug administration are required. 
Gold chloride is now known to be too toxic as far as injections 
into humans is of concern . But over the years, investigators have 
been interested in the biological effects of gold chloride in animals. 
Elftman, Elftman, and Zwemer (1946) carefully studied the histochemical 
distribution of gold following the intraperitoneal administration of 
gold chloride into rats and guinea pigs . A most interesting observa-
tion which they made was that the gold (chloride) was not reduced to 
the metallic state at the time of deposition in tissues; but, rather, 
he found in those t i ssues refractile granules of gold whose chemical 
nature remained undetermined, but may be related to the gold-protein 
complexes. The concentration of gold chloride deposition in animal 
organs decreased in the following order: epitheluim of the proximal 
convoluted tubules of the kidney; phagocytic cells, including the 
histocytes of connective tissue in general and the capsules of organs; 
the Kupffer cells; and the reticular cells of the lymph nodes. 
The total amount of gold chloride received by each animal ranged 
from 0.034 mg to 0.43 mg per gram of body weight. 
The biological effects of gold chloride were also reported by 
Orestano (1932). Orestano's findings were that when gold chloride is 
given hypodermically, it is partially absorbed, producing death with 
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large doses; the rest of the gold chloride (i "e . , the unabsorbed) is 
changed to metallic gold. Rapid i ntravenous injections resulted in a 
minimal lethal dose of 0.0008 g/kg of body wei ght. Orestano reported 
that the pharmacologic al action was due to the gold ion, which produced 
intense hemolysis and hemoglobinuria. The mineral was fixed in the 
red corpuscles more than in other parts of the body. Orestano 
described the follow ing transformation for gold chloride: complex 
gold i on+ gold cation+ metallic gold . 
As gold thioglucose and gold thiomalate pre soluble gold compounds, 
as is also gold chloride, after injections of these compounds, metallic 
gold was deposit ed in largest quantities i n the kidneys, which was 
in strik ing contrast with the larg e amount of gold that localized 
in the liver following injecti ons of colloidal gold compounds (Block, 
Buchanan, and Freyberg, 1942). Gold was also located in the heart, 
lungs, and spleen, as well as at the inj ect i on sit e, following admin-
istration of gold thioglucose and gold thiomalate . 
So far, we have been dealing with systemic abdominal distributions, 
which are the limiting distributions for colloidal gold and gold 
chloride as indicated by the available data . In addition to the 
abdominal distr ibutions of gold following the administration of gold 
thioglucose and gold thiomalate, it was demonstrated by Mayer (1960) 
and Wagner and DeGroot (1963) and subsequent investigators that the 
brain it self is invaded by these compounds. Gold deposit i on in brain 
tissue i s of great interest to psychologists because of the possi bility 
of associated behavioral effects . 
Gold thioglucose and gold th i omalate, which contain the metal in 
chelate linkage (Beckman, 1958), although not the only metals which 
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can penetrate the brain, are of particular interest to psychologists 
because studies have linked them with abnormal hypothalamic function-
ing and some nutritional problems (Mayer, 1960). The first study 
(Marshall, Barnett, and Mayer, 1955) demonstrated that gold deposited 
in the ventro-medial nucleus (VMN) of the hypothalamus after a single 
large injection of gold thioglucose int o mice. In addition to the 
VMN lesions demonstrated by Marshall, Barnett, and Mayer (1955), 
Liebelt and Perry (1957) demonstrat ed that significant lesions were 
also induced in the lymbic system of mice (i .e . , fornix, ventral 
psalternus, and primordial hippocampus), as well as in the hypothalamus. 
By 1960, Swartz, Christian, and Andrews (1960), using radioactively-tagged 
elements (i.e . , Au 198 and S32), observed the sites which gold and thio-
glucose each occupied at various intervals up to 48 hours following the 
gold thioglucose injections. They found labeled gold in the mouse's 
cerebrum, hypothalamus, and hindbrain . Mayer's (1960) work at that 
period indicated that hypothalamic lesions were produced in rats by the 
administrat io n of gold thioglucose, as well as i n mice, but the rats 
did not survive the massive doses because of toxic effects . Thus, 
Mayer concluded that while the lesions can be induced by gold thioglucose 
in rats, obesity cannot, since it requires the survival of the animal. 
In 1962, Debons et al , (1962), utilizing histological and autoradio-
graphic techn i ques, demonstrated that there was a predominant accumulation 
of gold in the middle section of the brain, which included the hypothal-
amus. The radioautographs indicated that although gold thiomalate 
penetrated brain tissue and was deposit ed as gold, the disposition was 
diffuse in comparison with gold thioglucose, in which the heaviest 
concentration was with i n the VMN of the hypothalamus. The animals which 
received gold thioglucose, but di d not develop hypothalamic obesity, 
characterized by hyperphagi a and subsequent obesity, had the lowest 
content of gold in the mi dsegment (whi ch included the hypothalamus). 
Debons et al , (1962) also injected 75 mi ce wi th gold thiomalate. 
Although none of the 75 mi ce became obese, there was a significant 
amount of gold noted i n the bra i ns of the gold thiomalate-treated mice. 
The distribution of gold i n the brai n of the gold thioglucose-treated 
non-obese animal was too diffuse to be localized in discrete areas 
even after prolonged exposure of radioautographs . It was also noted 
in this study that there was no r adi oautographi c evidence of gold 
accumulation in the hypothalamus of t he animals which were treated with 
gold thioglucose but did not become obese; nor di d any of the gold 
thiomalate-treated ani mals show radi oautographic gold localization in 
the hypothal amus, al though gol d was di str i buted diffusely throughout 
the brain in every case , 
Mayer (1960), af t er i nj ecti ng several hundred mice wi th varying 
dosages of organo-metall i c gold compounds, was abl e to establish 
statistics for l etha l dosages , 
Gold thiog l ucose was demonstr ated to be the only gol d compound 
to produce obesi ty i n the mouse, and the lethal dose (i , e . , LO 50) was 
dete rmined to be approximat ely 1.0 mg per gram of body weight--a 
dosage whi ch produced obesit y i n approximately 50 per cent of mice 
following inject i on, 
Although the hypothal ami c area i nvolved is often very large, only 
hyperphagia appears to resu l t (Marshall, Barnett, and Mayer, 1955), and 
it appears that the presence of the gl ucose component in the gold 
thioglucose molecule makes th i s restricted hypothalamic portion of the 
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blood-brain barrier much more permeable to this compound than to com-
pounds not containing glucose. The hypothalamic area containing the 
feeding centers had been previously postulated to contain "gluco-
receptors" (Mayer, 1953)o The lesions formed were permanent in 
animals which in fact became obese, but were not apparent in animals 
unsuccessfully injected o Gold thiomalate, though as toxic as gold 
thioglucose (Mayer and Marshall, 1956), did not cause obesity or 
hypothalamic lesions o Mayer and Marshall (1956) also tested sodium 
thioglucose along with the gold thiomalate. Sodium thioglucose and 
gold thiomalate injections of varying dosages did not produce obesity, 
while gold thioglucose (Marshall, Barnett, and Mayer, 1955) was 
responsible for observed obesity. Mayer and Marshall (1956) had shown 
that rats appear to be more susceptible to the toxicity of gold 
compounds in general . 
Brain damage, as a cause of gastric ulceration in animals, was 
first demonstrated by Schiff in 1846, and later confirmed by many 
investigators. More recent work indicates that the hypothalamus plays 
a prominent role in the formation of such lesions. Consequently, 
Deter and Liebelt (1962) injected rats intraperitoneally and intra-
muscularly in dosages of 0, 2 mg to 0. 5 mg per gram of body weight 
and reported that a s i ngle injection of gold thioglucose produced 
gastric ulcers and hypothalamic lesions in 100 per cent of injected 
rats if proper experimental condit i ons were chosen. Doses of gold 
thiomalate and gold chloride, which killed animals within 24 hours 
(Deter and Liebelt, 1962), produced neither hypothalamic nor gastric 
lesions; although in the case of gold chloride, animals injected with 
only Oo04 mg per gram of body weight of the compound killed three out 
of the 10 rats within 24 hours following injection. 
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Gunter and Ivy (1949) tested Hench's (1940) hypothesis that the 
ameliorating effect of gold in rheumatoid arthritis is perhaps analo-
gous to, if not basically i dent i cal wi th that induced by intercurrent 
jaundice . Gunter and Ivy used two dogs which were in good health, 
weighing 13. 2 and 14. 1 kg, as the i r subjects , They injected gold 
thioglucose and gold sodium th i omalate to both dogs for a period of 
three weeks. A total of 1500 mg of the combined drugs were administered 
to each dog (i . e, , 800 mg of gold sodium thiomalate and 700 mg of 
gold th i oglucose) . They followed the gold administrations with labora-
tory tests for liver function and the i r data indicated that in no 
case did any of the liver function tests show a variation beyond the 
normally accepted values . Thei r results did not support Hench's 
hypothesis that a case of jaund i ce follow i ng gold injections should 
relieve a patient's suffe ri ng. No behavi oral changes were reported 
by Gunter and Ivy (1949), although i t should be noted that in terms 
of the dog's body weight (i , e , , 14 kgms), and knowing that gold thio-
glucose has an LD50 of 1 mg per gm of body wei ght for mice (Mayer, 
1960), a div i ded dosage of 1500 mg represented approximately 10 per 
cent of the comparabl e lethal dose, Stil l, this amount was not suf-
f i cient to produce extens i ve hypothalami c effects in the animals. 
In rats, admi ni strat i on of subletha l dosages of gold thioglucose 
(i. e , , 0. 4 mg per gram of body wei ght (Wagner and DeGroot, 1963)) 
produced bilateral les i ons i n the ventromedi al aspect of the hypothalamus 
in 90 per cent of the rats, although obesi ty did not result at this 
dosage level . 
Chang and Persell i n (1968) injected gold thiomalate into guinea 
pigs (2. l mg gold sodi um thiomalate per week) and reported that the 
experimental subjects gained significantly more weight than the con-
trols . They detected gold in the hypothalamic and thalamic sections 
of treated animals when they used the techni que of neutron-activation 
analysis. Brain sections from control animals did not contain gold . 
Chang and Persellin's study (1968) extended the species generality of 
the brain effects of administration of gold compounds. 
Cortell and Richards (1942), using rat subjects, demonstrated 
the development of tolerance to gold salts in rats, using the survival 
method. They showed that rats given suble t hal dosages of gold sodium 
thiosulfate and of gold sodi um th i omalate could tolerate ordinarily 
lethal dosages of these compounds when subsequently administered. 
Denko and Anderson (1944) also used a similar technique to test the 
toxicity of gold compounds and noted that sublethal dosages of gold 
thioglucose showed a decided r i se i n blood nonprotein nitrogen values 
(a technique for quantifying one form of toxi ci ty) which returned 
to normal the fifteen t h day. When the dosages of gold thioglucose 
were repeated on these animal s, blood nonprotein nitrogen values 
remained normal . A third dose of 75 mg also showed no appreciable 
rise i n the blood nonprotei n nitrogen value , Gold compounds were also 
frequently swi tched i n th i s procedure, thus enabling Denko and 
Anderson (1944) to demonstrate both a direct tolerance and cross 
tolerance for the gold compounds. 
There are also a number of related metabolic factors affecting 
the deposition (and perhaps the transport) of gold thioglucose. For 
example, Edelman et al . (1965) have gathered data which indicate 
that glucose concentrations in the blood of the animal subject that 
prevailed at the time of the gold thioglucose injection was directly 
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correlated with the hypothalamic uptake of gold, with the extent of 
the hypothalamic lesion that resulted, and with the severity of the 
subsequent hyperphagia and obesity , They found that hyperglycemia or 
high blood sugar was associated with an increased gold deposition 
throughout the brain , 
Likuski, Debons, and Cloutier (1967) found that the glucose 
inhibitors, 2 deoxy-0-glucose and 2-amino-2 deoxy-0-glucose, both 
markedly inhibited gold thioglucose-induced hypothalamic obesity. 
Likuski, Debons, and Cloutier (1967) confirmed the hypothesis that a 
glucose inhibitor (such as 2 deoxy-0-glucose) interacts with cells in 
the postulated satiety center , Such metabolic inhibitors could sig-
nificantly affect the outcome of the gold thioglucose injection if 
they should occur in appreciable quantities in the animal's vascular 
system at the critical time. As for the environmental variables, 
Likuski, Debons, and Cloutier (1967) noted that the room temperature 
at the time of the gold thioglucose injection plays an important role 
in the incidence of obesity, obtaining a 100 per cent incidence of 
obesity by maintaining a constant room temperature of 21 C ± 2 Cat 
the time of the gold thioglucose administration . 
Behavioral Effects of the Gold Compounds 
Behavioral effects of drugs may be considered to be either desir-
able or toxic , Any undesirable behavioral characteristic may be 
-
defined arbitrarily as behavioral toxicity if it should follow the ad-
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ministration of a particular drug. Such a definition would be most 
arbitrary , The quest i on arises whether a more rational approach to the 
subject may be taken ~ The answer suggested is that the term 11behavioral 
toxicity" could be a general term for behavior resulting from a spe-
cific drug administration in which the consequent behavior is in some 
manner non-adaptive for a particular member of a species. Appropriate 
examples would be such effects as loss of thermoregulatory control 
for a species whose home is in a cold environment, or muscular spasms 
in an animal which normally has to maintain itself at treetop level , 
In such a context, behavioral toxic i ty becomes meaningful and, further-
more, clarifies what might be considered appropriate behavioral effects 
for a particular animal in a given environment , 
The behavioral effect which brought the gold compounds into 
prominence for psychologists and nutritionists was the result of an 
accidental finding made by Brecher and Waxler (1949) 20 years ago. 
A number of behavioral effects had been noted to be associated 
with hypothalamic lesions prior to 1949; i . e . , hyperexcitability 
(Hetherington and Ranson, 1942); abnormality of the reproductive 
organs, and of mating behavior (Bard, 1940; Dey, 1943). Waxler and 
Brecher (1949) injected mice with the organo-metallic chemical gold 
thioglucose in order to study the drug's toxicity . They noted that 
within days, the animal's size markedly increased , As a result, they 
decided to carefully investigate the phenomenon. Brecher and Waxler 
administered a single i ntraperitoneal injection of 25 mg to 35 mg of 
gold thioglucose to albino mice, with resulting marked weight gains 
in about 10 to 14 weeks. A post-mortem analysis was conducted for 
total body lipids, proteins, water, and ash. They concluded that the 
gain in weight in the mice was primarily due to an increase in adipose 
tissue. Brecher and Waxler (1949) described the characteristics of 
their gold compound. They stated that it was made up of 50 per cent 
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gold, was unstable in water, and was hygroscopic. To maintain the com-
pound in a stable form, they used sesame oil as the vehicle . Although 
gold thioglucose is fairly stable in aqueous solutions (Remington, 
1965), gold thioglucose in sesame oil allowed for even greater sta-
bility. Brecher and Waxler (1949) determined that the lethal dose, 
arbitrarily defined as the dose at which 50 per cent of the animals 
die, was 40 to 50 mg intraperitoneally for mice weighing 20 to 25 
gms. Fifty to 70 per cent of their animals survived doses of 35 mg 
of gold thioglucose, and 90 per cent survived dosages of 25 mg. All 
animals survived doses of 12 mg injected intraperitoneally. Fatal-
ities from the administration of gold thioglucose generally occurred 
during the first three to four days. There was no further mortality 
among those animals which survived one week, Only about one-third to 
one-half of the gold thioglucose-in j ected animals showed unusual weight 
gains. Animals that failed to show significant weight gains by the 
eighth week were given another 25 or 35-mg dose of gold thioglucose. 
Significant weight gains were subsequently observed in a number of 
reinjected ani mals. Animals, when given injections of only 5 mg of 
gold thioglucose intraperitoneally twice a week until a total of 150 
mg were given, fa i led to show any significant weight gains. All 
animals used in the above experiments were killed at the end of 14 
weeks, The viscera and the brains of both injected and control animals 
were examined microscopically . Except for centrolobular infiltration 
of the liver in obese animals, no anatomical lesions were formed in 
the organs examined. 
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The significance of hyperphagia (overeating) and subsequent obesity 
following the administration of gold thioglucose in mice subjects has 
stimulated research efforts by behavioral investigators and medical 
researchers concerned with nutrition. 
Following the investigations of Brecher and Waxler (1949), pos-
sibly the earliest use of operant procedures to study hypothalamic 
obesity was that of Miller, Bailey, and Stevenson (1950). By this 
date, it was known that gold thioglucose injections were followed by 
obesity in the mouse (Brecher and Waxler, 1949), but hypothalamic 
lesions had not been associated with the obtained data. 
Miller, Bailey, and Stevenson (1950) stereotaxically induced 
hypothalamic lesions in their subjects and sought to answer the ques-
tion of whether the marked increase in food intake produced by the 
lesion in the hypothalamic subject would be accompanied by increased 
performance in a variety of behavioral tasks motivated by hunger. The 
following procedures were used: (1) rate of bar pressing, reinforced 
by food at five-minute intervals; (2) amount of electric shock required 
to prevent approach to food; i .e . , negative reinforcement in an 
approach-avoidance situation; and (3) amount of food eaten in spite 
of a bitter taste (produced by mixing quinine with the food). Miller, 
Bailey, and Stevenson (1950) concluded that in ad libitum feeding 
situations, animals ate increased quantities of food following lesions, 
but generally did not work for the same quantities of food; i .e . , the 
udrive 11 to obtain food--as indicated by performance--was weak in 
comparison with expectations from the consummatory behavior noted in 
ad libitum feeding situations. 
The likelihood of a specific causal or functional relationship 
between a brain lesion and subsequent obesity in an animal subject, 
with an accompanying explicit statement of the mechanisms involved, 
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was explored in 1955. In that year, Bates, Zomzely, and Mayer (1955) 
noted that the instrumental behavior of overeating (hyperphagia) in 
obesity was not necessarily simple, as the hyperphagia may be the 
secondary result of an abnormal fat metabolism--either increased rate 
of synthesis, decreased fat mobilization and oxidation, or an imbalance 
between the two, with a net gain in favor of synthesis. It could 
also, they hypothesized, be due to an entirely different cause. 
A most enlightening study by Anliker and Mayer (1956) utilized 
operant procedures to measure feeding behavior patterns in demonstrating 
a change from normal feeding to increased intake at each meal with 
gold thioglucose-injected mice" Mayer (1953), who had written on the 
genetic, traumatic, and environmental factors in the etiology of 
obesity, and Anliker (Anliker and Mayer, 1956), undertook this inves-
tigation " Their subjects were mice with three types of obesity pro-
duced by different methods; i , e , , hypothalamic obesity, produced by 
stereotaxically lesioning the ventromedial nuclei of the hypothalamus; 
gold thioglucose obesity, resulting from a single injection treatment 
with gold thioglucose; and hereditary obese hyperglycemia syndrome, 
a Mendelian recessive characteristic that originated from crossing of 
11V stock" males and 11C57 Bll6 11 females , The cumulative records of 
Anliker and Mayer's study represented prolonged studies of several 
animals of each type and illustrate the food intake patterns. Anliker 
and Mayer (1956) were able to demonstrate that the over-all rate of 
feeding was greater for the hyperphagi c mi ce--i ncl udi ng go 1 d thi ogl ucose-
obese mice--than for the normal controls; and that waves or cyclic 
changes in rates of feeding were characteristic of normal mice, but 
were absent or barely discernible in the hyperphagic mice. They 
concluded that gold thioglucose-obese animals and hereditary-obese 
animals are the same, or approximately so, This conclusion was differ-
ent from the one reached by Bates, Zomzely, and Mayer (1955), when they 
noted that large differences existed between hereditary-obese mice 
and their siblings made obese by a single injection of gold thioglucose 
in relation to food intake and spontaneous exercise . 
Schmaltz and Issacson (1968) stereotaxically produced caudate 
lesions in rat subjects to test for retention and relearning of an 
operant reinforcement schedule. Transient, post-operative impairment 
was noted, and recovery on the schedule was generally noted by the 
tenth post-operative day. It was noted that impairment could be noted 
from the transient behavioral decrements; but the brain-damaged 
subjects recovered, although recovery required at least a week or two 
for reestablishing the baseline . Such results have possible implica-
tions for drugs damaging brain tissue . 
In 1960, Mayer reported that the hypothalamic lesions induced by 
gold thioglucose in mice are much more "purely" hyperphagic than 
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lesions induced in the same area by electrolytic coagulation. Although 
gold thioglucose lesions were widespread, they appeared to be selective. 
Mayer (1960) also reported that it is well known that there are all 
sorts of disturbances in functions other than food intake in animals 
in which les i ons have been induced electrolytically with a stereotaxic 
instrument; but by contrast, animals made obese with gold thioglucose 
seem to be only hyperphagic. They breed, have normal litters, and 
nurse their young, 
Mayerls report (1960) of normal breeding in mice following gold 
thioglucose administration was not supported subsequently, for in 1966 
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Rudali and Silberman (1966) injected female AkR mice intraperitoneally 
with gold thioglucose and subsequently observed that they were sterile. 
With male mice, they reported sterility in spite of normal spermato-
genesis . 
Although hyperphagia was the most frequently reported behavioral 
effect in mice since Brecher and Waxler1 s investigations of 1949, 
other behavioral effects of a toxic nature were reported by Wagner and 
DeGroot (1963) , Following the injection of 63 male Long-Evans rats 
with varying dosages of gold thioglucose (Wagner and DeGroot, 1963), 
varying from 0.1 to 0.75 mg per gram of body weight, within 12 hours 
after injection all rats exhibited aphagia, adipsia, enuria, evidence 
of lowered body temperature (i.e., shivering), increased sensitivity 
to a variety of stimuli, mild tremors, and the onset of convulsions, 
which invariably preceded death in rats given lethal dosages of gold 
thioglucose. Such symptoms are additional manifestations of behavioral 
toxicity attributed to gold thioglucose administration. 
In the case of gold thiomalate, reactions have been attributed 
to the compound during arthritic therapy. Strauss, Barrett, and Rosen-
berg (1950) report that toxic reactions to gold in humans resulted 
from small amounts in some cases and large amounts in others. In one 
patient, only 20 mg of gold were sufficient to induce a serious reaction; 
in another, toxicity did not appear until 7900 mg had been administered. 
In 86 per cent of the cases, the toxic reaction to gold consisted of 
pruritis, dermatitis, or stomatitis . Occasional bone marrow depression, 
hepatitis, or nephritis was reported , 
In the case of gold, as had been suggested (Root et al . , 1954), the 
administration of Au1 98 intraveneously causes little untoward effects 
in the patient. In a few cases (Root et al . , 1954) there was anorexia 
for a few days; and in one patient, transient liver tenderness. Liver 
function tests showed no significant changes following the gold admin-
istration . 
Gold chloride is now known to be quite toxic, so that the most 
predictable effect following appreciable dosage administration would 
be the death of the subject. 
Behavioral toxicity has already been previously attributed to 
gold thioglucose administration to humans; i . e . , psychiatric disorders, 
central and peripheral nervous system manifestations (Sundelin, 1941), 
and polyneuritis leading to flaccid paralysis of all limbs (Leiper, 
1946). Such disorders, not conducive for adaptation to the environ-
ment, fall under the behavioral toxicity classification . 
Although most toxic effects of gold compounds in the case of 
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human subjects are expressed as verbal expression or operant behavior, 
an interesting exception (i , e . , electro-physiological evidence) was 
reported by Patterson and Dale (1966). They reported that more abnormal 
EEG frequencies, particularly fast wave findings, appeared in rheuma-
toid arthritis patients who had received large amounts of gold over a 
period of many years . 
It became evident from data obtained from many sources that the 
neuroanatomical, neurophysiological, and behavioral changes following 
administration of gold compounds were much more complex than they were 
previously believed to be. From Mayer's (1960) work, it was indicated 
that gold thioglucose lesions are associated with hyperphagia and 
obesity in mice, but not with gonadal dysfunction. Liebelt and Perry's 
(1957) data indicate that significant lesions were induced in the 
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limbic system, as well as in the hypothalamus, thus directing future 
research into the area of limbic damaged tissue, and possibly associated 
emotional changes. Swartz, Christian, and Andrew's (1960) administra-
tion of gold thioglucose into mice indicated a widespread deposition 
of gold into brain areas, with the probability of modifying behavior 
and reliev i ng pain through the alteration of pain pathways. Debons 
et al 's . (1962) data demonstrated differential deposition of gold in 
brain regions following the administration of gold thioglucose or 
gold thiomalate and the differential gold deposition in the hypothal-
amic areas following the injection of gold thioglucose and gold 
thiomalate . Brecher et al . (1965) obtained experimental data which 
indicated that the ventro-medial nucleus of the hypothalamus did not 
have to be the damaged tissue associated with the subsequent obesity; 
but rather, that the glucoreceptive sites may be widespread as to 
anatomical site . Likuski, Debons, and Cloutier (1967) showed that 
glucose inhibitors can interact with the hypothesized anatomical depo-
sition s i tes, thus prevent i ng the fixation of gold to hypothalamic 
tissue . Reynold's (1965) data and his proposed irritative theory, 
although in agreement with the experimental findings of widespread 
gold deposition, allowed for the irritation of the lateral hypothalamus, 
but contradicted the theoretical foundations of the old explanatory 
hypothesis for the mechanisms controlling food intake . This contra-
diction created a need for new experimental approaches and effort . 
Finally, Hoffman and Whistler ' s (1968) data on the effects of thioglu-
cose--which were assumed to be non-contributory--turned out to be quite 
metabolically significant, causing a temporary glucosuria and hyper-
glycemia, and thus complicated the interpretations of the effects 
which followed the administration of gold thioglucose into animals and 
humans. 
Cox, Kakolewski, and Valenstein's (1969) most recent study of 
ventro-medial hypothalamic lesions and changes in body weight and food 
consumption in rats was closely allied to that undertaken at Utah 
State University. Subjects were both male and female rats, four months 
of age. After two weeks of baseline measurements, Cox, Kakolewski, 
and Valenste i n's experimental animals received bilateral lesions of 
the ventro -medial hypothalamus, utilizing a stereotaxic instrument. 
Controls were subjected to the same treatment as the experimental 
subjects--including free feed--except that stereotaxic lesioning was 
omitted in the case of the controls . Female controls did not vary 
significantly in weight duri ng the three weeks following surgery 
from their initial weight (i . e., 275 gms). In the case of the ventro-
medial hypothalamic damaged subjects, weight averages increased from 
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an initial weight of approximately 275 gms to a final weight of slightly 
over 350 gms--indicating hyperphagic behavior . Lesioning of the ventro-
medial hypothalamus (Cox, Kakolewski, and Valenstein, 1969), then, led 
to substantial demonstrable weight gain in female rats within a three-
week period follow i ng stereotaxic lesioning of the ventro-medial 
hypothalamus. 
The Characteristics of the 
Measurement Technique 
An essential consideration with operant procedures, particularly 
an escape schedule (since the escape schedule was utilized in these 
studies), was the ratio length effect noted in Dinsmoor and Winogard's 
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( 1958) study. The responding rate of subjects on shock schedules was 
analyzed after first stabilizing the animals for several sessions at a 
given level of current and then taking a new series of readings at 
higher or lower shock levels. Their data indicated that as shock was 
i ncreased, response rate increased, and visa-versa. Although the rate 
of response generally increased with increase in shock intensity--
assuming that the subject did not stop responding altogether--there 
was an important length of ratio effect which was of particular sig-
nificance with drug studies . Winogard (1965) studied escape behavior 
under different fixed ratios and shock intensities. His data indicated 
that for a subject on a long fixed ratio (e.g., FR20), the rate is 
lower than for a short fixed ratio (e .g. , FR5). The difference in 
rate for different length schedules (Winegard, 1965) might be attributed 
to breaks occurr i ng after the ratio run was under way. These breaks 
or pauses have been called "strain" by such investigators as Boren and 
Ferster and Skinner (Winogard, 1965). From such data it can be assumed 
that on long ratios (e.g . , FR20), if rates of response by the subject 
are very high, the strain will be eliminated and drug effects should 
be less than, for example, the same FR (ratio) in which the subject 
responded at a lower rate and, consequently, strain was notable . With 
a s hort fixed ratio there was generally no strain and the rate of re-
sponding was at a higher rate (Winogard, 1965) so that less disruption 
by drugs was to be expected . It is evident from Winogard's data that 
rate changes following drug administration on a long ratio might not 
be comparable to those for a short ratio, so that the investigator might 
bene fit by using at least one additional ratio length, either much longer 
or s horter than the main ratio for the experimental schedule. 
The dose-curve relationship (Thompson and Schuster, 1968) is a 
very useful conventional pharmacological technique for measuring 
behavioral changes in the experimental session following the injection 
of a drug . It is often assumed, consequently, that the behavioral 
changes noted on the curve during the session are due to, or 
associated with, the drug action. 
In the case of drugs such as the gold compounds, however, the 
concept has to be stretched to include post-experimental drug sessions. 
Under such conditions, samples of behavior demonstrated in the curves 
before drug injection must be compared with sample sessions after the 
injection. In this connection, for example, Barnes and Stoner (1959) 
studied the action of triethyl tin . Rats were given a single dose at 
about the LD50 for that drug, producing a transient narcotic action, 
after which the animal at first recovers (Barnes and Stoner, 1959), 
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and then over the next two to three days it becomes quieter and 
progressively weaker and dies. Obviously, should such rats be subjected 
to operant procedures the first session, or even the first several 
sessions--although producing a definite drug dose-curve effect--taken 
individually it provides insufficient data for interpretations, and 
would be quite misleading if the before and after records were not 
studied session by session to note in what sessions the drug had its 
maximum or minimum effects ', even though only one injection had been 
administered. 
Barnes states the problem when he notes that 
many drugs that affect behavior can have the most rapid 
and dramatic effects which are nevertheless completely 
and often equally rapidly reversible . A number of 
centrally acting poisons, on the other hand, act much 
more slowly but in many cases irreversibly , (Barnes, 
1964, p . 172) 
The latter statement possibly applies to gold compounds. 
Summary and Interpretations of the 
Gold Compounds Literature 
The chemical characteristics of drugs, as well as their distribu-
tion in the organism and their biological, as well as behavioral 
effects, when considered in relation to each other--as mentioned 
earlier--allow for a rational interpretation of effects, as well as 
providing a framework for inferences and predictions. 
Gold thioglucose and gold thiomalate, existing as chelates, in 
some not-too-well-understood fashion maintain the ionic or partly 
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ionic state of the gold part of the molecule, and thus provide a 
possibility for a slow but reactive gold interaction with biological 
materials prior to some sort of deposition in the tissues. The com-
pounds are both soluble, and since reactions are protected, the drugs 
may travel extensively throughout the body of an animal or man prior to 
reacting with tissue . Wagner and DeGroot1 s (1963) data, in which 
animals were sacrificed within 48 hours after treatment, provided 
histological evidence for hypothalamic lesions, clearly showing that the 
drug must distribute itself widely within that time. This would include 
passing the blood-brain barrier, in order for the compound to reach 
its deposition site within the hypothalamus, Swartz, Christian, and 
Andrew's (1960) data indicated that gold thioglucose could be picked 
up in high concentrations in the brain within two hours. 
Gold chloride, being a trivalent gold compound, is the most 
reactive, but it has not been localized in brain tissue. As Orestano 
(1932) claimed, it was highly reactive, damaging tissues rapidly and 
widely as it became distributed, with renal damage that led to 
fatality . Gold chloride, then, might be considered the most toxic of 
these gold drugs, although the toxicity must be restricted to abdominal 
areas at the current state of our knowledge. 
Hoffman and Whistler's (1968) finding that the thioglucose part of 
gold thioglucose increases the glucose levels of the blood temporarily 
and Deter and Liebelt's (1962) finding of gastric lesions associated 
with the hypothalamic lesions both contribute markedly to the anorexia 
which is reported when higher dosage levels are administered (Wagner 
and DeGroot, 1963). 
In the case of gold thiomalate, in spite of the similarity of the 
drug in structure to gold thioglucose it is known to diffuse in all 
areas of the brain (Debons et al . , 1962), rather than concentrating 
in the VMN of the hypothalamus (as with gold thioglucose); and from a 
chemical point of view, it is more soluble and more ionic than gold 
thioglucose . Such a chemical difference can lead to greater reactivity 
and toxicity for gold thiomalate in comparison with gold thioglucose . 
Behaviorally, colloidal gold would seem to fall into the rela-
tively inert status, gold chloride toxicity should lead to deteriora-
tion of behavior and finally death; while gold thioglucose and gold 
thiomalate administration should fall in between. For example, the 
drugs in human administration have been followed by clinical reports 
in which the arthritic condition is improved (Drill, 1954) in a per-
centage of the cases, particularly where toxicity occurs. The patient 
frequently reports that the subjective experience of pain associated 
with the joint disease is reduced. Gold thiomalate has also been 
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used routinely for years in animal arthritis with reports of observed 
improvement in the locomotion of the animal (Fennel, 1969), thus 
demonstrating behavioral modification effects . 
The most obvious difference between gold thiomalate and gold 
thioglucose and the other two gold compounds (i . e . , gold and gold 
chloride) is that the two organic-metallic compounds deposit in both 
the body and brain of most species studied so far; but in the case of 
gold and gold chloride, whatever are its systemic effects, the drugs 
reportedly do not penetrate the brain. 
An important consideration in relation to all gold compounds 
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deals with what the pharmacologists call pharmacodynamics. Typically, 
drugs (e .g. , phenobarbital) are soluble in biological tissue, are 
distributed rather evenly except for the target organ (where the con-
centration is assumed to be greater), and do their work (i.e., pharmo-
codynamics) by temporarily depressing or stimulating a particular tissue 
or organ, and are subsequently eliminated. In the case of the gold 
compounds, the most obvious implications for a pharmacodynamic explan-
ation must include the fact that gold compounds are quite different 
from most classifications of drugs in that the final end-product of a 
gold injection includes the deposition of metallic gold within tissue. 
Not only can function be altered by such tissue alterations, but the 
probability of differential deposition of the gold on a particular 
occasion following drug administration could conceivably produce 
variability in effect in the same manner that neuro-surgical operations 
produce unpredictable after-effects on patients. This characteristic 
of gold would tend to produce variability in demonstrable functional 
relationships for the drugs . Furthermore, the evidence for tolerance 
of gold compounds (Cortell and Richards, 1942; Denko and Anderson, 
1944), using a non-protein nitrogen index, would be expected to be 
reflected behaviorally in a more constant response rate over sessions 
following the development of tolerance to the toxic drugs. 
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STATEMENT OF THE PROBLEM 
A major problem of interest in relation to gold compounds and 
their effects on different species is the apparent discrepancy between 
the brain lesion and obesity produced in mice following administration 
of a large gold thioglucose dose and the apparent absence of similar 
phenomena in rats and other species, including man. The therapeutic 
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gold thioglucose injections of patients suffering from rheumatoid 
arthritis have not been associated to date with brain lesions or obesity. 
Hypotheses stated in relation to the basic research design and 
data collection techniques include the following: 
1. Gold thioglucose and gold thiomalate effects following injec-
tion are different from those obtained either from gold or gold 
chloride , 
2. Gold thioglucose and gold thiomalate should decrease response 
rates due to the neurological damage they induce. 
3. Gold chloride, because of its reactivity, should be highly 
toxic to rats. 
4. Colloidal gold, because of its inertness, should produce no 
behavioral effects . 
5. Gold thioglucose-lesioned (or assumed to be lesioned) subjects 
should not react in the expected fashion under conditions in which 
anaphylactic shock would be expected. 
6. Some differences in behavior might be expected following admin-
istration of gold thioglucose and gold thiomalate because of their 
chemical differences and different brain deposition . 
7. Paralleling the data indicative of biological tolerance for 
gold compounds (Denko and Anderson, 1944), behavioral tolerance or 
adaptation following repeated administration of either gold thio-
glucose or gold thiomalate should be demonstrable. 
8 , Hyperphagi a and weight gain in rat subj ects could follow 
admini stration of heavy dosages of gold thioglucose . 
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EXPERIMENT I 
Since colloidal gold strongly contrasts with gold thioglucose and 
gold thiomalate in reportedly being chemically inert, it was used as 
a gold control. Sesame oil served as a vehicle control. Based on this 
chemical difference, it was expected that gold would affect the animal 
in the same manner behaviorally as other gold compounds, but to a 
lesser extent . Gold chloride was reduced to elemental gold in sesame 
oil. It was assumed that the gold was primarily of colloidal size 
after reduction , 
Method 
Subject 
A single Long-Evans female rat (Rl2), three months of age, served 
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as the subject . The rat had not been previously used as an experimental 
subject . 
Apparatus 
The apparatus consisted of a relay-timer switching apparatus and 
an operant conditioning chamber equipped with a lever, stimulus lights, 
and a scrambling grid for shock delivery. The relay-timer switching 
apparatus is programmed for controlling behavioral contingencies . In 
addition, a cumulative recorder allowed for event recordings, such as 
lever-pressing responses. 
Automatic recording of the number of responses emitted by Sis 
programmed, as well as number of reinforcements, time out (or relief 
from shock) delivered, inter-response times (IRT's), and the number 
of time-out responses; i.e., responses following shock termination . 
Procedure 
36 
In the Escape Schedule utilized in this experiment, the operant 
behavior or response is reinforced by the termination of an unconditioned 
negative reinforcer, such as electric shock (Thompson and Schuster, 
1968). The negative reinforcer or shock (i.e . , S-) controls the occur-
rence of the responses. 
The establishment of a baseline, incorporating the response 
rates data of a number of sessions prior to administrating a drug, 
allowed for utilization of the procedure in which e~ch subject could 
serve as its own control, with baseline data serving as the criterion 
for interpretation of response rate variations associated with drug 
injections, as well as variations during the post-drug injection 
sessions . (See Cox, Kakolewski, and Valenstein, 1969.) 
At each experimental session, the subj ect (Rl2) was lifted out 
of its home cage, weighed, carried i nto the experimental room, and 
placed in the operant chamber (after being observed on the balanced 
beam apparatus). The experimenter (E) left the room after turning on 
the apparatus. This initiated a 50-minute experimental session 
utilizing an Escape Schedule , 
The initial experimental sessions consisted of training the rat 
to respond to terminate shock. This was accomplished by initially 
terminating shock after each bar press (i .e., FRl or CRF), followed 
by increasing the number of bar presses which had to be emitted in 
, order to terminate the shock for 30 seconds , The subject was trained 
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to a terminal level of a fixed ratio of 20 responses (i.e., FR20), 
followed by a 30-second relief or time out from shock. Following 
termination of a session, the animal (Rl2) was returned to its cage 
where it had free access to food and water at all times. 
The baseline response rates for Rl2 varied from 20 to 75 responses 
per minute--a rather wide baseline base--prior to initiating the drug 
series (Figure 1). The last pre-in j ection session 1 s data (i . e., 75 
responses per session) indicated that Rl2 had attained a rapid and 
dependable response rate pattern on an FR20 Escape Schedule, with the 
probability of maintaining a high rate of response in subsequent 
sessions. 
Following the establishment of the pre- i njection baseline band, the 
injection period proper was begun. In this part of the procedure, the 
subject was run on an FR20 for approximately 10 minutes warm-up (i.e., 
the initial) prior to receiving a drug inj ection . The actual recorded 
exper imental session was init i ated by the intraperitoneal injection of 
the drug . The recording sess i on lasted 50 mi nutes. 
Inject i on procedures were based on the usual procedures (Thompson 
and Schuster, 1968). These included dosage calculations based on 
known LO 50 levels for gold thioglucose as reported by Wagner and 
DeGroot (1963) for the rat . 
Following the establ i shment of the baseline, Rl2 was initially 
injected with 0. 5 cc of sesame oil to screen for undesirable effects 
from the vehicle . The injection series for Rl2 consisted of the 
following injections of gold suspended in sesame oil, in which each 
drug injection session was followed by at least one or more non-drug-
injection sessions, thus allowing for recovery of the baseland band 
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response rate prior to injecting once again: 10 mg, 10 mg, 25 mg, 
25 mg, 50 mg, 50 mg, 75 mg, 75 mg, and 100 mg. The subiect was subse-
quently given a single 25-mg gold thiomalate injection. Following 
recovery of the baseline, a final 200-mg injection of gold thioglucose 
was administered and escape behavior was followed for several additional 
sessions . At least one or more recording session followed each drug 
administration, depending on whether the response rate departed from 
the baseline . The criterion vehicle which was used consisted of no 
appreciable deviation from the baseline band. The technique of 
allowing for recovery of the baseline after a drug injection and then 
repeating the procedure was followed . It is the intrasubject replica-
tion technique (Sidman, 1960) which increases the experimenter's 
confidence in the reliability of resulting data with few subjects. 
Results 
Calculations were made daily following the termination of an 
experimental session to determine the results of that session, and 
char ted so that deviations from the baseline could be made apparent. 
Figures 1 and 2 represent the complete experiment for Rl2, as well as 
an indication of response rate deviations from the initial baseline 
and body weights of the pre-drug administration period. 
It is apparent from the graphs that for all gold injections through 
session 27, rates of response were confined to the wide baseline band 
(Figure 1). The subject's response rates increased significantly 
above baseline levels following the last gold injection, increasing 
to over 100 responses per minute for several sessions. 
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Rl2 was subsequently injected with a single gold thiomalate injec-
tion of 25 mg. In the subsequent two sessions, response rates fell 
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from over 100 to 13 responses per minute, the lowest rate in the experi-
ment and well below the baseline band. Recovery to above baseline 
levels (i.e., 50-60) was noted in the subsequent three sessions. A 
final injection of 200 mg of gold thioglucose was administered to Rl2. 
Response rates fell to less than 30 responses per minute on two sessions 
(i.e., at the lowest rate within the baseline band) without achieving 
recovery at the termination of the experiment . 
The response rate drops following gold thiomalate and gold thio-
glucose administration were quite significant, as at 15 or 20 responses 
per minute, qualitative changes in behavior are evident. Furthermore, 
no recovery from the gold thioglucose was evident at the termination 
of the experiment, indicating the possibility of permanent behavioral 
changes, associated with extensive hypothalamic damage as a result of 
the heavy 200 mg dose of gold thioglucose . 
As for weight fluctuations (Figure 2), the general trend was toward 
a slight increase upward (i .e . , from 290 to 320 gm), although a tem-
porary large weight drop was observed following the 100 mg injection of 
gold, the 25 mg injection of gold thiomalate, and the 200 mg dose of 
gold thioglucose . 
Discussion of results 
Until the gold injection series had been completed, the general 
trend was quite misleading, for in checking Figure 1, it was evident 
that the baseline response rate was not altered by the gold injection 
series; i.e., the response rates for most of the sessions fell in the 
middle of the baseline band at around 40-50 responses per minute. In 
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the sessions following the 100 mg gold injection, however, the average 
daily response rate increased from an average of approximately 40 to 
50 responses per minute to 100 or more responses per minute. It can 
be determined by graphic inspection in retrospect, that gold administra-
tion suppressed the response rate potential, as evidenced by release 
of suppression in the sessions following discontinuance of gold 
administration, in which response rates increased markedly, probably 
associated with detoxification processes. 
The injection of 25 mg of gold thiomalate which followed the gold 
injection series was associated with a drop in response rate from an 
average of over 100 responses per minute to a low rate of 13 responses 
per minute. This decrement was followed by a recovery of response 
rate to the initial baseline rate four days following this gold thio-
malate injection. It can be noted (Figure 1) that the decrease in 
response rate did not follow the administration of gold thiomalate 
during the drug injection session, although 24 hours later a drop in 
rate was quite evident . 
The final 200 mg gold thioglucose in j ection did not affect response 
rate during the drug session, although in the following sessions the 
response rates fell to a low level . Baseline recovery rate did not 
occur prior to the termination of the experiment . 
The temporary weight losses which were observed suggested that 
there were toxic effects due to the chemical compounds on either hypo-
thalamic centers or other parameters of the animal's biochemistry. 
A likely explanation for the apparent long-term suppression of 
behavior following gold thioglucose administration as opposed to the 
temporary suppression noted with gold might be related to the differential 
biological distributions of the two compounds. In the case of gold, 
deposition is limited to abdominal organs. With gold thioglucose, the 
gold deposition is localized abdominally (Block, Buchanan, and Frey-
berg, 1942), as well as hypothalamically (Debons et al., 1962). 
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EXPERIMENT 2 
Gold thiomalate (Myochrisne) is a drug which has been routinely 
used on humans and is, therefore, equally important as gold thioglucose 
from a medical point of view. 
Method 
Subjects 
Three female rats (Long-Evans strain--R4, R5, and RlO) were used 
in this experiment . They were three months old at the start of the 
sessions and were experimentally naive . 
Apparatus 
The same apparatus was utilized as described in Experiment 1. 
Procedures 
The same procedures were utilized as in Experiment 1 except for 
changes in drug dosages . 
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R4 and R5 were given identical dosages. Dosage schedule was as 
follows: vehicle injection, gold thiomalate 10 mg, 25 mg next day (for 
possible desensitization effects), then 10 mg, 25 mg, and 50-mg dosages. 
RlO, on the other hand, was injected twice with gold thiomalate 10-mg 
dosages following the sesame oil control injection . Except for the 
combined 10-25-mg dose for R4 and RS initially, all drug injections 
were followed by recovery of baseline prior to reinjection. 
Results 
The initial double dose of 10-25 mg of gold thiomalate was not 
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followed by departure from the baseline in R4 or R5. Consequently, a 
second dose of 10 mg of gold thiomalate was administered to the two 
subjects . In the case of R5, death occurred within 48 hours, which was 
preceded by a profound drop in rate on the last session . Response 
rates dropped extremely below the baseline band of 30-45 responses per 
minute for the f i ve preceding sessions (Figures 3 and 4). R4's record 
was quite similar to that of R5's, but subsequently, recovery of the 
baseline rate occurred . R4 was next inj ected with a 25-mg dose of 
gold thiomalate. Baseline recovery took almost two weeks following this 
25-mg injection . A final 50-mg dose of gold thiomalate resulted in a 
decreased rate from which the animal failed to recover its baseline 
activity prior to termination of the experiment (Figures 5, 6, and 7). 
In the case of RlO (the third thiomalate subject), a single 10-mg gold 
thiomalate injection depressed rates of responding for nearly two weeks 
before recovering the original baseline rate. A second 10-mg gold 
thiomalate dose was in j ected into RlO with no apparent baseline recovery 
at termination of the experiment (Figures 8 and 9). 
As for weight flu ct uations, the striking similarity in curves 
for weight loss and response rate drops for all three gold thiomalate 
subjects (i . e . , R4, R5, and RlO) indicates that there is a high prob-
ability that toxic abdomin al effects from the gold thiomalate may 
contribute primarily to the response rate decrease in gold thiomalate-
injected subjects . Also, response rate decrememts are demonstrable 
for weeks or longer following a gold thiomalate injection, thus 
indicating the long-term toxic effects . Finally, tolerance is indicated 
by the larger dosages (e.g., 50 mg) being tolerated (e . g., R4) without 
pronounced toxic reactions visible . 
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Discussion of results 
Because of the high solubility and partial ionic state of the gold 
thiomalate, the investigator attempted to "desensitize" animals R4 
and R5 with an initial 10-mg dose followed by a 25-mg dose the follow-
ing day. This could be considered to be a prolonged 35-mg injection, 
from a conservative point of view. The data from Figures 3 through 7 
indicate that following combined gold thiomalate injections, response 
rate did not fall off on the following session (i.e., the baseline band 
response rates for R4 and R5 were maintained). Consequently, an 
additional 10-mg dose followed for both R4 and R5. Within 48 hours, 
R5 died, but R4 survived, although response rate dropped drastically 
for both subjects. Consequently, a rough LD 50 (i .e . , lethal dose for 
half the number of subjects) could be put at about 35 mg, or 0.15 mg 
per gram of body weight for gold thiomalate in mature Long-Evans female 
rats . 
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Fast interresponse times (IRT's) generally corresponded (Figure 6) 
with a rapid response rate, indicating that no great change had occurred 
in non-responding while the shock treatment was on. It can be noted 
that from a mathematical point of view, should a reversal occur for 
fast IRT's (i .e . , high per cent of fast IRT's with a low response rate 
per minute), then the conclusion reached would be that non-responding 
is increasing at a disproportionately high rate (i.e . , if per cent of 
fast responses is high while overall response rate is low, the few 
slow responses must be very long). 
As for weight changes, in the case of R4 the weight chart closely 
parallels the response-per-minute chart, indicating a relation between 
the assumed index of toxicity (i.e., weight loss) and the associated 
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response behavior (i.e., drop in response rate). The relation should 
not be considered as exact, since the operant response of eating is not 
likely to be perfectly related to the loss of the reinforcer's (food) 
strength from liver toxicity, brain effects, or other biological 
concomitants . 
It can be concluded from these data that injections of gold thio-
malate are followed by a large drop in response rate as well as rapid 
weight loss within 24 to 48 hours following administration, although 
eventual recovery of baseline may be noted . A fourth subject (Rl2) 
had also received a gold thiomalate injection (25 mg) (see Experiment 1) 
with similar results. As gold thiomalate administrations are repeated, 
the tendency toward drug tolerance in rats can be inferred from the 
data. 
EXPERIMENT 3 
Gold thioglucose is not only important because it is a medical 
therapeutic agent in rheumatoid arthritis (i.e., Solganol), but lesions 
produced in the VMN of the mouse hypothalamus (Marshall, Barnett, and 
Mayer, 1955) have opened up a new avenue of behavioral and physiolo-
gical research into obesity resulting from overweight, overeating, and 
associated emotional changes. 
Method 
Subjects 
Four three-month-old female Long-Evans rats (R7, R9, Rll, and R6) 
served as the subjects for this experiment. They were naive prior to 
the experiment. 
Apparatus 
The apparatus used in this experiment was the same as for Experi-
ments 1 and 2. 
Procedures 
Procedures were the same as in the previous experiments, except 
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for drug dosages, which were individualized--not only because of subject 
variability, but also because of the different schedules and baseline 
rates. (The subject of schedule effects has been considered in an 
earlier section.) 
R9 was a rapid FR20 responder (i.e., baseline band of 80 to 100 
responses per minute). R7 was a medium-rate responder on a fixed ratio 
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of 20 (i.e . , from over 40 to over 50 responses per minute baseline band) . 
Rll and R6 were on an FR12 Escape Schedule, both stabilized on a fairly 
low response rate (i.e., 10-20 responses per minute for R6 and 20-30 
responses per minute for Rll 's baseline level). The drug dosages for 
each subject are indicated in the graphs (i.e., Figures 10 through 21). 
A return to baseline activities was attained in the majority of 
the sessions. Higher dosages of the drugs were given when activity 
was below the established baselines to study effects of increasing 
dosages when baseline recovery was practically unachievable without 
attempting retraining procedures. 
Results 
After the establishment of the high response rate baseline for R9, 
the injection series was initiated. Following the control injection of 
0. 5 cc of sesame oil, a combined 10-25-mg gold thioglucose dosage was 
given to provide for desensitization should sensitivity be involved. A 
profound drop in response rate occurred (i.e., down to approximately 
60 responses per minute per session), which remained below the baseline 
band for three sessions . This was followed by a recovery of the initial 
baseline. A second 10-mg dose was administered to R9, which also 
brought the rate down to approximately 60 responses per minute (Figures 
11 and 12) prior to once again attaining the baseline . This was 
followed by a series of double 25-mg and 50-mg injections without any 
drop below the baseline band. The final 50-mg gold thioglucose dose 
was associated with a drop in rate to 60 responses per minute, well 
below the baseline band. After nine days without recovery of the 
baseline, the subject was injected with 150 mg of gold thioglucose to 
study the effects of a much heavier drug administration. Following 
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this injection, response rates dropped much lower, resulting in almost 
complete deterioration of the fixed ratio behavior, in contrast to the 
high and stable response rates evident two weeks previously for R9. 
Weight fluctuation data for R9 is quite significant in its lack of 
correspondence with response rate data . Although weight drops are 
evident following some of the heavy gold thioglucose dosages, weight 
recovery is quite complete within several sessions, in contrast to the 
absence of response rate recovery for the gold thioglucose. For 
example, following the 150 mg gold thioglucose administration, response 
rates dropped drastically with no apparent recovery; while weight 
losses--although falling far below the baseline--were recovered, result-
ing in the highest final weight recorded during the experiment for R9. 
Following the vehicle injection into R7 (Figures 13, 14, and 15), 
a 10-mg dose of gold thioglucose was given the animal. R71 s response 
rate did not fall below the established baseline based on the following 
session. Consequently, a second 10-mg gold thioglucose injection was 
administered. The rate dropped as a result of the treatment. Since 
the original baseline was not reestablished, after two weeks the 
animal was injected with a 50-mg gold thioglucose dose to note behavioral 
effects superimposed upon an activity level below the baseline response 
levels. No substantial response rate changes in the direction of base-
liQe recovery were noted prior to the death of the subject. 
R6 (Figures 16, 17, and 18) received a vehicle injection, a 10-mg 
gold thioglucose injection that was followed by a 50-mg, 135-mg, and 
finally a 300-mg gold thioglucose injection. After this treatment, an 
anaphylactic reaction occurred and death ensued. Wide fluctuations 
in response rate were noted throughout the experiment with R6 (i.e., both 
increases and decreases in rate following administration of the drug, 
almost totally within its baseline band of 10-25 responses per minute). 
For Rll (Figures 19, 20, and 21), which was on an FR12 escape 
schedule and had a low rate of 10 to 25 responses per minute for its 
baseline band, an inconsistent response pattern, within baseline 
limits, was recorded , 
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For all four subjects, weight fluctuations were relatively minor 
(Figures 12, 15, 18, and 21), except for the large weight drop following 
the 150-gm gold thioglucose injection into R9 and the 135-mg injection 
into Rll , 
Discussion of results 
In the case of R9, a rapid drop in response rate was demonstrated 
following the first 10-25-mg gold thioglucose injection . There was a 
subsequent recovery of baseline rates , A second phase of relative 
stability of response rates followed, and this was associated with a 
number of increasing dosages of gold thioglucose administrations. The 
most likely explanation for the observed stability was the development 
of tolerance. Subsequent deterioration of response rate without a 
continuation of addi tional injections points to the possibility for 
cumulative toxic effects which overcame the organism's tolerance 
capacity . 
R71 s rapid deterioration of response rate could be attributed to 
the 11strained 11 character of its response behavior--recognized in the 
intermediate baseline response rate of approximately 40 to 50 prior to 
drug injection--and to subsequent toxicity noted in the observation of 
tremors development following the 50-mg gold thioglucose injection. 
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Subsequent lethal effects point to the particular sensitivity of R7 to 
gold thioglucose . 
R6 and Rll had stabilized at a low rate of response (i.e., 10-30 
responses per minute) with a relatively short ratio (i.e., 12), and 
were not subsequently appreciably affected by gold thioglucose injec-
t i ons. This effect was probably due to both the ease of responding 
at low rates on a short ratio, and possible tolerance development to 
the increasing dosages . No decrease in response rate over several 
sessions was noted in the case of Rll. Schedule effects did correspond 
with Winogard1 s (1965) predictions; i.e., greater stability associated 
with drug effects with subjects trained under short fixed ratios. 
Furthermore, lack of pronounced weight fluctuations, except 
following very heavy dosages of gold thioglucose, point to the rela-
tively less toxic nature of gold thioglucose in comparison with the 
large weight fluctuations following gold thiomalate injections. 
The major differences between gold thioglucose and gold thiomalate 
were that weight losses were associated with the injection of gold thio-
malate following most drug administrations, but with gold thioglucose 
injections, only the heavier dosages affected body weight significantly. 
Also, when both short and long fixed ratios were considered, as well 
as response rates associated with the ratios in all subjects, it is 
evident that gold thiomalate injections were always followed by decrease 
in response . In the case of gold thioglucose, rate decrements generally 
accompanied only the heavier dosages and then only in strained ratio 
conditions. For example, Rll, on a low-rate FR12 ratio, was not 
appreciably affected by the 300-mg gold thioglucose dose; while in the 
case of the strained character of R71 s response record--an intermediate 
response rate subject--gold thioglucose drug administrations were 
followed by a definite downward trend in response rates. 
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EXPERIMENT 4 
In 1960, Mayer stated that although rats can be injected with heavy 
gold thioglucose dosages compared to mice (i .e . , 1 mg per gram of body 
weight), and hypothalamic lesions consequently form, the rat does not 
survive the toxicity and consequently cannot become obese as is the 
case in approximately 50 per cent of injected mice. 
Method 
Subjects 
Six rats served as subjects for this ethological study. Three were 
male Long-Evans rats, over three months of age. The other three subjects 
were female Long-Evans rats which had been run on escape schedule 
procedures and administered gold thioglucose injections prior to the 
final part of the study. 
Equipment 
In this investigation, injections required the utilization of 
syringes . Weighing was by means of a balance, accurate to the nearest 
0.1 gram. 
Procedures 
The three male rats were injected with 1.0 mg per gram of body 
weight of gold thioglucose. Rl, the fourth subject (female), was injected 
as follows: 10 mg on a morning session, 50 mg 48 hours later, 145 mg 
96 hours later, and 300 mg 96 hours later , Three hundred mg corresponded 
to over 1.0 mg per gram of body weight for Rl. (See Figures 22 and 23.) 
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R6 (female) was injected in the same dose and interval (i.e., as Rl) 
between drug injection series. Rll, the sixth subject, was injected in 
graduated gold thioglucose injections, which included the following 
dosages: 10 mg, 25 mg, 50 mg, 135 mg, and 300 mg. 
Results 
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The three male rat subjects were dead in their cages on the follow-
ing morning. This phase of the experiment replicated Mayer1 s (1960) 
finding; i.e., that a single l mg per gram of body weight injection of 
gold thioglucose is fatal to rats. 
Rl 1 s progress can be seen in Figure 22. The subject survived the 
very heavy dose of 1.0 mg per gram of body weight, thus providing the 
basis for rat hyperphagia and consequent obesity (Mayer, 1960). Within 
the first 10 days after treatment, no large weight increases were noted 
for Rl. A weight reduction was noted on the first day following the 
300-mg injection, but recovery was complete in several days, with no 
obesity . Following experimental session resumption, response rates 
increased above the baseline levels (Figure 22). 
R6 died within two minutes after the 300-mg injection, with symptoms 
indicative of an anaphylactic reaction . Rll survived the initial 300-mg 
dose and completed the requirements of the FR12 escape schedule for 
that day (i . e., 50 minutes of operant responding). It also survived 
the 300-mg injection and maintained its operant behavior on the following 
days, prior to the termination of the experiment. 
Discussion of results 
In relation to the massive final gold thioglucose injection, indi-
cations of drug toxicity based on weight loss were minimal. Rl and Rll 
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survived the 300-mg dosage of gold thioglucose. By developing tolerance 
to the drug, it would appear that much heavier dosages of gold thio-
glucose can be injected into a rat . 
It is possible that since the data for Rl and Rll establish a 
precedent for a probable increase in the tolerance for gold thioglucose 
in rats, increases in the size of the hypothalamic lesions, as well 
as behavioral changes, may be expected in rats. With these dosages, 
similar lesions and behavioral changes may occur in higher species. 
Rl, which initially failed to respond to shock, responded at a 
relatively high rate following the 300-mg gold thioglucose injection, 
possibly due to neurological alterations which affected the behavioral 
sets (Figure 22), thus allowing for greater flexibility of response, 
possibly associated with changes in drive states. 
ADDITIONAL OBSERVATIONS 
Gold Thioglucose and the 
Anaphylactic Response 
A most interesting phenomenon that impinges on physiology and 
behavior both is the anaphylactic reaction--sometimes fatal--and the 
lesser reactions which seemingly stem from the same cause. Luparello, 
Stein, and Park (1964) investigated the possibility that following 
hypothalamic damage (and, consequently, likely autonomic malfunc-
tioning), a decrease in anaphylact i c reactions might result in hypo-
thalamically-damaged rats . Positive results were obtained . 
Method 
Subjects 
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Two rats of the Long-Evans stra i n served as the subjects . The 
control subject was a normal non-in j ected animal. The experimental 
subject, Rl3, was a rat which had been i nj ected with 40 mg, 70 mg, and 
100-mg dosages of gold thioglucose within a 72-hour period approximately 
four months prior to the exper i ment. 
Materials 
The sensitizing drug for the experiment was sodium levothyroxine. 
Egg white was the protein made available for injections . 
Procedures 
Although the problem of developing an anaphylactic reaction in the 
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rat is fraught with difficulties, particularly as rats are quite 
resistant to anaphylactic shock (Sanyal and West, 1958), the method of 
sensitization found successful by Leger (1947) was attempted. The two 
subjects were first injected with 0.15 cc of egg white. During the 
following 12 days, the two subjects were tube-fed the 100 gamma of 
sodium levothyroxine and were otherwise on free feed. At the end of the 
12-day sensitization phase, each subject was injected with 0.3 cc of 
egg white. 
Results 
No immediate reactions were noted. Within 90 minutes, the feet, 
as well as the area surrounding the mouth, of the normal rat swelled 
extensively. In the case of the experimental rat, no such swelling 
appeared to occur . 
Discussion of results 
Although the investigator considered the total procedure to be 
of an exploratory nature, rather than quite reliable, the swelling 
noted with the normal rat and absent in the gold thioglucose-injected 
rat points to the possibility that hypothalamic-lesioned tissue of 
the experimental animal may have been causally related to the supporting 
mechanisms for anaphylactic reactions . The possibility of a successful 
replication of such phenomena would lead to a technique of studying 
neurological contributions to allergic conditions. 
Balance Beam Apparatus 
Nineteen categories describing rat behavior were arbitrarily 
developed prior to the initiation of the experiment. In the sessions 
prior to the establishment of a relat i vely stable baseline, it was 
noted that some of the proposed categories di d not correspond to the 
observed behavioral traits. F~rthermore, a gradual reduction in the 
initially observed behavior was evident in later sessions that preceded 
drug administration . 
The subj ects were the same rats run on the escape operant pro-
cedures, including Rl, R6, R7, and R9 with gold thioglucose; R4, RlO, 
and R5 on gold thiomalate injections; and Rl2 on all three (i .e., gold, 
gold thioglucose, and gold thiomalate) . 
Subjects were repeatedly placed on the beams for a total count of 
five times (Figure 24), after which they were observed for the balance 
of the allotted three minutes. All observat i ons were recorded daily on 
the mimeographed sheets (see Appendix), i ncluding weight of the subject 
whi ch was obta i ned by wei ghi ng each animal prior to placements on the 
beam apparatus . Indi vi dual obser vat i ons of each subject were made 
dai ly by th i s procedure . 
Walled enclosu re Placement beam 
Figure 24. Balance beam apparatus. 
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Data were subjected to a statistical analysis, utilizing per cent 
frequencies (see Appendix Table 1). Baseline behavioral activities in 
per cent of occurrence (based on the last 10 days prior to initiating 
drug injections) were compared with post-baseline drug-injected sessions 
following . In this study, subjects served as their own controls. 
A statistical analysis of the data indicates that mobility on the 
high beam (see Appendix, number 5), return to beams (number 12), and 
climbing on beam apparatus enclosure (number 19) distinguished baseline 
behavior from drug sessions. Activ i ties of the above categories 
decreased for most of the subjects. Also the time for remaining on 
beam (number 18) following placements on the beam was a useful criterion, 
as time on the beam increased following drug administrations. 
The most likely explanation for the above results is that difficult 
motor activity, such as is represented in numbers 5, 12, and 19, is 
reduced in frequency following abdominal and possibly neurological 
alterations in subj ects, as well as overall reduction in movement (number 
18). As for weight fluctuat i ons throughout the several experiments 
(see Appendix Table 1), eight of the nine subjects gained only 5.5 gm 
from age three months at the initiation of the experiment, through the 
drug and post-drug injection experimental sessions. 
In the case of the gold, gold thioglucose, and gold thiomalate 
subjects, the heavy i nj ections were often associated with a temporary 
weight drop, followed by slightly increasing weight gains in the sub-
sequent sessions (Figures 2, 7, 9, and 12). The biological effects 
which had been demonstrated to be associated with the administration 
of the above compounds are kidney damage and liver damage (i.e., abdominal 
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organ damage) (Block, Buchanan, and Freyberg, 1942), as well as ventro-
medial hypothalamic lesions for gold thioglucose (Wagner and DeGroot, 
1963). 
In connection with weight changes, the above weight fluctuations 
noted correspond to Cox, Kakolewski, and Valenstein's (1969) control 
group weight, rather than the experimental group which had been 
stereotaxically lesioned in the ventro-medial hypothalamus. The 
apparently insignificant long-term weight changes in the case of the 
gold thioglucose-injected subjects at Utah State University argues for 
an hypothesis that abdominal damage associated with anorexia and 
hypophagia counters or compounds the characteristic hyperphagia and 
obesity which accompanies ventro-medial hypothalamic damage; and such 
damage is assumed to have occurred in all or most of the Utah State 
University subjects injected with 0.5 mg per gram of body weight or more 
of gold thioglucose (Wagner and DeGroot, 1963). 
Because of the likelihood of extensive damage at both the abdom-
inal as well as the hypothalamic levels, hyperphagia and obesity would 
probably not be observed due to antagonistic cancelling effects, 
although other behavioral effects associated with extensive hypothalamic 
lesions could be expected. 
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OBSERVATIONS ON THE EFFECTS OF GOLD CHLORIDE 
Gold chloride has long been known to be a toxic drug (Drill, 1954), 
and is consequently no longer utilized in medical practice. The 
interest in the drug from a behavioral pharmacological point of view 
stems from the fact that the gold moiety of the compound is highly 
ionic, providing it with the potentiality of rapidly destroying 
tissue. Studies of a pharmacological nature concerning its action 
have consequently not been carried out in decades. Its hypothesized 
high toxicity had led to the ignoring of the possibility of CNS 
involvements. Being of no potential importance in medicine or 
behavioral research, the drug effect was not studied with the more 
precise operant procedures. It was felt that gross observations would 
suffice. 
Method 
Subjects 
Two female rats, one of the Long-Evans strain and the other 
Albino, served as the subjects , The subjects were experimentally 
naive and were three months of age. 
Equipment 
Aqueous gold chloride and syringes were available in the laboratory 
for injection. 
Procedures 
Because of the attributed toxicity of the drug, the following two 
dosages were administered: 20 mg on the first session; skip several 
days, 50 mg on the second session. 
Res~lts 
In the case of the Albino rat, following the injection of a 20-mg 
gold chlor i de dose no noticeable effects were noted. In 48 hours, a 
second dose of 50 mg was administered . S was dead in its cage on the 
following morning. Autopsy performed by the investigator revealed 
that no clumping or ot her signs of gold could be found at the site of 
injection (intraperitoneally). 
The Long-Evans subject was also injected with a 20-mg injection 
of gold chloride initially. Effects were extremely profound, incapa-
citating the subject so that it was unable to walk by the second 
post-injection date . Death followed soon afterwards, and consequently 
a higher dosage was not required . 
Discussion of results 
Gold chloride i s evidently the most toxic of the gold compounds 
whi ch have been consi dered . It appears to be completely absorbed 
within the GI tract, as none was evident intraperitoneally. From the 
i ncapicitation of the Long-Evans subj ect prior to death, massive 
biological damage could be assumed, although CNS tissue damage could 
not be ruled out from the evi dence noted . 
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DISCUSSION 
Rl2 received gold, gold thiomalate, and gold thioglucose injections 
in Experiment 1, providing a meaningful intrasubject comparison, since 
all effects occurred in the same animal, with its own unique behavioral 
characteristics. 
That the colloidal gold suppressed response rate of the subject 
was inferred from the rapid increase in response rate that surpassed 
and doubled that of the original baseline level following discontinuance 
of colloidal gold administration. 
In the experiments which were performed, gold thiomalate was 
associated with response rate decrement and pronounced downward trends 
in recorded weights of treated subjects. 
Following graduated gold thioglucose administrations, tolerance 
was evidenced from the relatively stable daily response rates, even 
with increasing dosages and the relatively minor weight changes 
observed in the subjects . 
In all four gold thiomalate subjects, for example, a correspondence 
between toxic effects--assumed from loss of weight--and response rate 
drop was noted . This relationship was particularly evident in R4's 
record. 
In Experiment 3 (i.e., R9, R7, R6, and Rll), gold thioglucose was 
the drug injected . Weight changes were minor, probably due to the 
lesser toxicity of the compound. 
Tolerance of heavier gold thioglucose dosages was noted in R91 s 
chart, where the 25 through 50-mg injec tio ns did not affect the 
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baseline activity during a number of sessions to any appreciable 
degree . 
The second experiment, utilizing R4, R5, and RlO, demonstrated 
the effects of baseline rate for short and long fixed ratios (i .e., 
FR12 and FR20) with associated gold thiomalate injections. Behavior 
was rapidly disrupted by higher dosages (i.e., 10 mg to 25 mg, in the 
case of gold thiomalate), and recovery was very slow on strained fixed 
ratios. Relearning might definitely be a factor in recovery from gold 
thioglucose and gold thiomalate effects in view of the many sessions 
required for recovery of such baselines. 
A final 50-mg dose of gold thioglucose proved to be fatal to R7, 
indicating that the rat could not tolerate large doses of the drug. 
The data suggest the possibility that injection spacing might affect 
the maintenance of a tolerance state. An interval spacing of greater 
than three to four days (e .g., 12 days in the case of R7) might no 
longer sustain the same tolerance levels in the subject upon subse-
quent injections. 
R6 and Rll, responding to low ratios (i.e., FR12) and intermediate 
response rates (i .e., 25-35 responses per minute), were not demonstrably 
affected by gold thioglucose (i .e., either steady increase or decrease 
in response rate). The data point to the importance of the schedule 
ratio and learned response rate for maintaining baseline behavior. 
The explanation would probably be that when behavioral response require-
ments are minimal, or nearly so, the animal can continue responding 
at a similar rate in spite of toxic drug effects. 
An observation that was made in the case of Rll 's record was that 
in spite of injections of gold thioglucose up to a final dosage level 
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of 300 mg (double that required for demonstrable hypothalamic lesions 
(Wagner and DeGroot, 1963)), no significant daily response rate changes 
were noted on the graph . This demonstrates that response rates on 
short ratios may be maintained following the administration of the 
highest gold thioglucose dose of 300 mg. 
Ethological studies on Rl were preceded and followed by escape 
schedule sessions . The subject was not run the week following the 
massive gold thioglucose injection to allow for recovery from the 
initial toxic effects . When Rl was subsequently run on escape, the 
long periods of non-responding which were observed early in training 
were no longer evident, although no adequate explanation could be 
given. 
In all studies with gold thioglucose (Wagner and DeGroot, 1963; 
Mayer, 1960; Debons et al . , 1962) that utilized several species, the 
hypothalamic damage which occurred could be assumed to be of comparable 
magnitude to that following stereotaxic lesioning of the hypothalamus. 
Since following stereotaxic lesions, anaphylactic shock has been 
demonstrated to be reduced in i ntensity or elimi nated (Luparello, 
Stein, and Park, 1964), the same possibility for chemically-induced 
lesions was assumed in this investigat i on. The supporting evidence 
from a single observation made on the one control and one experimental 
subject was positive . Since anaphylactic reactions of a minor sort 
are difficult to differentiate, additional studies and replications 
would be advisable. 
The balance beam apparatus generally indicates that in establishing 
a behavioral baseline, only a few of the initial responses emitted by 
the rat subjects were retained. Injections of gold compounds lead to 
the reduction of difficult motor responses; particularly, mounting of 
the beam enclosure--a frequently-emitted response in establishing the 
baseline prior to the drug injections . The possibility of utilizing 
the beam apparatus profitably with stimulating drugs was entertained, 
since with stimulating drugs an expansi on of baseline activities could 
be hypothesized. 
Gold chloride was considered worthwhile to study, although it was 
known to be highly toxic (Drill, 1954) from studies conducted several 
decades ago. The justification for replication of its effects is that 
it is a gold compound, its gold being highly ionic (Orestano, 1932), 
which is the assumed characteristic responsible for its toxicity. 
A single gold chloride iniection of 20 mg killed R2 within two 
days, while two injections (25 mg and 50 mg) killed the Albino subject, 
lending support to the hypothesis that ionic reactivity is associated 
with toxic effects of gold. The lesser ionic characteristic of the 
coordination complex compounds, gold thioglucose and gold thiomalate, 
could well account for their effects, including brain reactivity 
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(i.e., combining with neurological tissue) . The greater ionic charac-
teristic of the gold thiomalate compared with that of gold thioglucose 
(Drill, 1954) would probably account for its greater toxicity when these 
two similar chelating compounds are compared. 
The answer to the problem stated earlier could probably be that 
gold compounds would have the same effects in humans as they have in 
the mouse if comparable doses were administered . This is based on 
the fact that gold penetration of brain tissue has been noted in several 
species. Such a procedure is inconceivable in humans because of its 
damage potential. These comparable dosages could be achieved in man 
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through the development of tolerance induced by gradual dosage in-
creases as demonstrated in this study . 
With the gold thioglucose injections administered routinely to 
humans, lesions are unlikely, although gold deposition in the brain 
could probably be demonstrated from a spectroscopic analysis. 
As for the hypotheses described below based on the experimental 
data, most were confirmed. 
Hypothesis 1: Colloidal gold suppressed behavior. Gold chloride 
was toxic to the animal and killed it easily. Gold thioglucose and 
gold thiomalate neither killed all the animals (as would have been the 
case with gold chloride), nor were they limited to suppressing behavior 
(as was the case with gold). Instead, they profoundly influenced 
rates of responding within a day or two after injection . Behavior was 
often disrupted for a week or two pr i or to recovery. 
Hypothesis 2: Gold thiomalate as well as gold thioglucose were 
associated with response rate decrements, particularly on the longer 
ratios (i .e., FR20). A more pronounced and more reliable drop was 
associated with the admi nistrat i on of gold th i omalate. Associated 
weight losses generally followed the gold thiomalate administration. 
Although gold thiomalate and gold thioglucose have abdominal 
distributions similar to collo i dal gold (Block, Buchanan, and Frey-
berg, 1942), their brain distributions probably would account for 
disruptive effects on behavior, where gold seems to only suppress 
behavior (conclusion from Rl2 data). 
Hypothesis 3: Gold chloride proved to be highly toxic to rats, 
probably due to its ionic character, as previously postulated (Orestano, 
1932). 
Hypothesis 4: Colloidal gold, although chemically inert, did 
affect the subject's behavior; it also suppressed response rate. 
Hypothesis 5: Gold thiog l ucose--assuming that the subject was 
hypothalamically -lesioned--poss i bly mi ght have prevented anaphylaxis. 
No generalized conclusion can be made concerning the anaphylactic 
reaction on the basis of the l i mi ted evi dence gathered. 
Hypothes i s 6: Gold th i omal ate was more toxic and disruptive of 
response rate than gold thioglucose, and loss of weight was much more 
profound following the in j ections of gold thiomalate when compared 
with gold thioglucose. This differen ce could be attributed to the 
greater ionic character of the th i omalate compound. 
Hypothesis 7: Since the work of Denko and Anderson (1944) had 
indicated that tolerance and cross-tolerance between gold compounds 
occur in an organism, it would be expected to be expressed behav-
iorally. Following the gradual i ncrease of gold thioglucose dosages, 
tolerance was noted behaviorall y i n constant rates from session to 
session in one subject (R9). Ani mals sur vi ved heavy dosages of gold 
thioglucose and response rates were with i n baseline limits once bio-
logical tolerance had been developed i n several rats. 
Hypothes i s 8: Although large hypothalamic lesions were probably 
associated with a heavy concentr ation of gold thioglucose administra-
tion, hyperphagia and obesi ty di d not follow, probably due to anorexia 
and hypophagia associated with l i ver and kidney damage, confounding or 
countering the hyperphagia result i ng f rom gold thioglucose-induced 
hypothalamic lesions . 
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CONCLUSIONS AND RECOMMENDATIONS 
Conclusions 
1. Gold (colloidal) suppresses response rates on an operant escape 
schedule. Termination of drug administration leads to an almost 
immediate increase of response . 
2. Gold thiomalate and gold thioglucose decrease response rates 
significantly with subjects on escape schedules following a fairly large 
initial dose (i.e., 25 mg for gold thiomalate and approximately 50 mg 
for gold thioglucose). The decrease occurred more regularly in the 
case of gold thiomalate. 
3. Gold thiomalate is more toxic than gold thioglucose, being 
associated with a much greater drop in response rate on an operant 
schedule following an equivalent dosage to gold thioglucose, as well 
as a temporary loss of weight in the subject . 
4. Graduated dosages lead to tolerance of gold thioglucose in 
rats, so that a formerly considered lethal dose of 1 mg per gram of body 
weight can be tolerated by the subject , 
5. Replication studies with gold chloride confirmed its highly 
toxic and lethal effects on rat subjects at relatively low dosages 
(i.e., 25-50 mg). 
Recommendations for Medical Therapy 
with Gold Compounds 
1. Results from these studies indicate that should treatment with 
gold compounds for rheumatoid arthritis be indicated, gold thioglucose 
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is favored over gold thiomalate because of the apparent greater inferred 
toxicity of gold thiomalate indicated by the experimental data. 
t 
2. A change of scheduling of dosages from the conventional method 
of an initial 10 mg at intervals to a total of 750 mg (Remington, 
1965) to much lower dosages in order to establish and maintain toler-
ance with fewer undesirable effects , 
3. Since clinical evidence, including EEG studies on humans 
(Patterson and Dale, 1966), indicate brain effects following the admin-
istration of gold thiomalate and gold thioglucose, histological and 
spectroscopic brain examinations on deceased patients who had been on 
the drugs is recommended. This would probably lead to the removal of 
the gold compounds from therapeutic utilization. 
Behavioral Recommendations 
1. Further anaphylactic reaction studies on the effects of gold 
thioglucose administration on allergic reactions in animals should be 
undertaken. 
2. Studies on the development of tolerance to gold thioglucose in 
cats, monkeys, and dogs should be undertaken so that the massive dosages 
required for producing extensive hypothalamic lesions may be achieved. 
This would allow for the analysis of brain damage-associated behavioral 
changes utilizing a chemical lesioning technique , 
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APPENDIX 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
Three-Minute Observations Following Placements 
of a Subject on the High Beam 
of the Apparatus 
Sub.iec;ts 
#1 #2 #3 #4 #5 #6 #7 #8 #9 
Weight prior 
to placements 
Passively falls 
off high beam 
Resists but falls 
off high beam 
Stationary on 
high beam 
Mobile on 
high beam 
Rearing on 
high beam 
High and low 
beam mobility 
High-low-high 
beam mobility 
Floor 
mobi 1 i ty 
Stationary on 
floor 
Floor 
rearing 
Return to I 
beams 
Beam/floor ratio I 
high or 1 ow 
Twisting or 
rolling on 
floor 
(ipsilateral) 
Turning head 
on floor 
(contralateral) 
Flip-fl ops on 
floor 
Number of I 
boluses 
Time on beams 
fo 11 owing five 
placements 
Jumping on top of 
large enclosure 
99 
#10 #11 #12 
100 
Table 1. Frequency percentages of observed behavior over pre- and post-
drug sessions 
Num- Combined 
ber Rl R4 R5 R6 R7 R9 Rl 0 Rl 1 R12 group percent 
Weight in grams 
1 
Ba 239 257 231 272 282.8 256 258.9 256. 1 292.5 
Aa 289 258 232 274 297.9 263 266.0 256.8 302.0 
Percent 
2 B 0 100 0 0 100 0 0 20 0 A 33 100 0 0 100 0 0 12 0 
3 B 0 0 0 0 0 0 0 0 0 A 0 0 0 0 0 0 0 0 0 
4 B 81 0 0 0 0 0 0 0 0 A 100 0 0 0 0 0 0 0 0 
5 B 92 36 9b 0 20 10 0 80 30 31 (#5) A 0 0 0 0 0 0 0 67 0 11 
6 B 36 0 0 0 0 0 0 80 0 A 0 0 0 0 0 0 0 62 0 
7 B 0 0 0 0 0 0 0 10 0 A 0 0 0 0 0 0 0 4 0 
8 B 0 0 0 0 0 0 0 0 ,ob A 0 0 0 0 0 0 0 0 0 
9 B 0 100 100 100 100 100 100 90 100 A 0 100 100 93 100 92 100 84 100 
10 B 0 0 0 0 0 0 0 0 0 A 0 0 20 0 0 0 0 0 0 
11 B 0 100 100 100 100 100 100 100 100 A 0 100 80 93 97 84 100 87 100 
12 B 0 lOOb 36 0 0 30 40 1 ob 60 31 ( # 12) A 0 0 20 0 0 8 0 0 5 4 
13 B 100 0 0 0 0 0 0 80 0 A 94 0 0 0 0 0 0 92 0 
14 B 0 0 0 0 0 0 0 0 0 A 0 0 0 0 0 0 0 0 0 
15 B 0 0 0 0 0 0 0 10 0 A 0 0 0 0 0 0 0 49 0 
16 B 0 0 0 0 0 0 0 0 0 A 0 0 0 0 0 0 0 0 0 
17 B 9 0 0 0 0 0 0 0 0 A 6 0 0 0 0 0 0 70 0 
Time on beam 
18 B 180 6 5.3 5. 1 6 5. 3 5. 1 100 6.8 35. 5 ( # 18) A 170 13 5.2 5.7 11.9 5. 1 9.7 113 17.5 39. 1 
Percent 
19 B 0 100 100 71 40 90 80 100 70 72 (#19) A 0 41 60 0 24 36 17 83 11 30 
as= Before drug treatments (baseline); A= After drug 
bFrequency = Significance cannot be determined. 
treatments. 
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